Illumina, Inc. vs Kimberly Clark Corp — how do they compare? Illumina, Inc. trades at $193.3 (market cap $29.12B), while Kimberly Clark Corp trades at $108.02 (market cap $36.11B). The key difference: Kimberly Clark Corp is the larger of the two by market cap, and Kimberly Clark Corp pays a 4.72% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | KMB | |
|---|---|---|
Market Cap | $29.12B | $36.11B |
Sector | Health | Consumer Staples |
52-Week High | $205.10 | $134.81 |
52-Week Low | $91.00 | $93.05 |
Enterprise Value | $30.48B | $41.67B |
Dividend Yield | — | 4.72% |
Trailing returns across standard periods
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →